Galena Biopharma, Inc. 4

4 · Galena Biopharma, Inc. · Filed Jan 31, 2014

Form 4

Period: 2014-01-29

Director

Transactions

Exercise/Conversion
Stock Option (right to buy)
2014-01-29−50,000→ 0 total
Exercise: $2.31Exp: 2021-01-13→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2014-01-29−50,000→ 0 total
Exercise: $1.71Exp: 2023-01-29→ Common Stock (50,000 underlying)
Exercise/Conversion
Common Stock
2014-01-29$0.72/sh+50,000$36,000→ 203,500 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-29−50,000→ 0 total
Exercise: $0.72Exp: 2022-01-12→ Common Stock (50,000 underlying)
Exercise/Conversion
Common Stock
2014-01-29$2.31/sh+50,000$115,500→ 53,500 total
Exercise/Conversion
Common Stock
2014-01-29$1.18/sh+100,000$118,000→ 153,500 total
Exercise/Conversion
Common Stock
2014-01-29$1.71/sh+50,000$85,500→ 253,500 total
Sale
Common Stock
2014-01-29$5.28/sh−250,000$1,320,000→ 3,500 total
Exercise/Conversion
Stock Option (right to buy)
2014-01-29−100,000→ 0 total
Exercise: $1.18Exp: 2021-03-24→ Common Stock (100,000 underlying)

Footnotes (4)

[F1]The option vested in equal quarterly installments of 12,500 on each of March 31, 2011, June 30, 2011, September 30, 2011 and December 31, 2011.
[F2]The option vested in equal quarterly installments of 25,000 on each of June 25, 2011, September 25, 2011, December 25, 2011 and March 25, 2012.
[F3]The option vested in equal quarterly installments of 12,500 on each of April 12, 2012, July 12, 2012, October 12, 2012 and January 12, 2013.
[F4]The option vested in equal quarterly installments of 12,500 on each of April 29, 2013, July 29, 2013, October 29, 2013 and January 29, 2014.

Documents

1 file